ANLN and cancer: Anillin resides not only in the nucleus of interphase cancer cells, but also in the cytoplasm, and anillin expression can have either positive or negative outcomes for patients depending on the cancer type and anillin’s subcellular localization (Hall et al., 2005; Suzuki et al., 2005; Ronkainen et al., 2011; Liang et al., 2015; Magnusson et al., 2016; Wang et al., 2016; Idichi et al., 2017; Zhang et al., 2018).